Does RIBOCICLIB Cause Cholelithiasis? 83 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Cholelithiasis have been filed in association with RIBOCICLIB (KISQALI). This represents 0.3% of all adverse event reports for RIBOCICLIB.
83
Reports of Cholelithiasis with RIBOCICLIB
0.3%
of all RIBOCICLIB reports
15
Deaths
41
Hospitalizations
How Dangerous Is Cholelithiasis From RIBOCICLIB?
Of the 83 reports, 15 (18.1%) resulted in death, 41 (49.4%) required hospitalization, and 10 (12.0%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which RIBOCICLIB Alternatives Have Lower Cholelithiasis Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN